Breast Cancer
-
Musical Toxicity an Effect of Cancer Treatment
Study finding cancer treatment affects ability to play or sing music highlights need for physical therapy, experts say.
by Kyle Bagenstose
-
Overcoming Resistance
People with metastatic hormone receptor-positive breast cancer are living longer, thanks to new targeted therapies and endocrine therapies that can be prescribed when treatment resistance develops.
by Kendall K. Morgan
-
Q&A
A Journey of Self-discoveryKailee McGee’s short film explores how a breast cancer diagnosis reshaped how she sees herself.
by Tyler Santora
-
Treating HER2-ultralow Breast Cancer
FDA approval expands treatment options for people with metastatic breast cancer that expresses minimal levels of HER2.
by Sandra Gordon
-
Screening Options for People With Dense Breasts
Reports on breast density inform women of their status but raise questions about what to do next.
by Robin Roenker
-
Delaying Treatment Resistance
Adding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
-
Rethinking the Role of Radiation
Chest radiation may not be necessary for people with intermediate-risk breast cancer.
by Thomas Celona
-
Understanding the Federal Rule on Breast Tissue Density Reports
Screening mammography reports will include breast density and an explanation in common language.
by Sandra Gordon
-
Forward Look
A More Targeted PARP InhibitorEarly research suggests treatment could have higher potency and less toxicity for people with BRCA-related cancers.
by Marci A. Landsmann
-
Breast Cancer: Making Treatment Decisions
With additional treatment options and an emphasis on reducing side effects, patients with breast cancer have more decisions to make than ever before.
by Natalie Slivinski